262 related articles for article (PubMed ID: 18971634)
1. Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.
Kwak S; Nishimoto Y; Yamashita T
RNA Biol; 2008; 5(4):193-7. PubMed ID: 18971634
[TBL] [Abstract][Full Text] [Related]
2. Determination of editors at the novel A-to-I editing positions.
Nishimoto Y; Yamashita T; Hideyama T; Tsuji S; Suzuki N; Kwak S
Neurosci Res; 2008 Jun; 61(2):201-6. PubMed ID: 18407364
[TBL] [Abstract][Full Text] [Related]
3. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
[TBL] [Abstract][Full Text] [Related]
4. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
[TBL] [Abstract][Full Text] [Related]
5. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
6. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
[TBL] [Abstract][Full Text] [Related]
7. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
[TBL] [Abstract][Full Text] [Related]
8. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
[TBL] [Abstract][Full Text] [Related]
9. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
[TBL] [Abstract][Full Text] [Related]
10. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
Källman AM; Sahlin M; Ohman M
Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
[TBL] [Abstract][Full Text] [Related]
11. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
Kwak S; Kawahara Y
J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
[TBL] [Abstract][Full Text] [Related]
12. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
13. Substrate recognition by ADAR1 and ADAR2.
Wong SK; Sato S; Lazinski DW
RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
15. Specificity of ADAR-mediated RNA editing in newly identified targets.
Riedmann EM; Schopoff S; Hartner JC; Jantsch MF
RNA; 2008 Jun; 14(6):1110-8. PubMed ID: 18430892
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
[TBL] [Abstract][Full Text] [Related]
17. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
Hosaka T; Tsuji H; Kwak S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
[TBL] [Abstract][Full Text] [Related]
18. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
[TBL] [Abstract][Full Text] [Related]
19. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
